The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancer
Authors:
- 1 February 2011
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 120 (2) , 233-238
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Extracellular, circulating proteasomes and ubiquitin — Incidence and relevanceBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2008
- Role of Surgery in Ovarian CarcinomaJournal of Clinical Oncology, 2007
- Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: A non-randomized comparison using an explanatory analysis: A Gynecologic Oncology Group studyGynecologic Oncology, 2005
- Heightened levels of circulating 20S proteasome in critically ill patientsEuropean Journal of Clinical Investigation, 2005
- High plasma proteasome levels are detected in patients with metastatic malignant melanomaBritish Journal of Dermatology, 2005
- The proteasome: structure, function, and role in the cellCancer Treatment Reviews, 2003
- Incidence of ovarian cancer by race and ethnicity in the United States, 1992-1997Cancer, 2003
- The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of ConstructionPhysiological Reviews, 2002
- Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasmaJournal of Immunological Methods, 2002
- Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignanciesCancer, 2001